BeStock  
Markets › Compare › MAZE vs ZYME

MAZE vs ZYME

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MAZE · Maze Therapeutics$31.37 ▼ 3.27%
ZYME · Zymeworks$26.14 ▼ 2.68%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5679101124146Nov 24, '25May 26, '26Nov 20, '26
  • MAZE -14.4%
  • ZYME +4.6%

Head to head

MetricMAZEZYME
Price$31.37$26.14
Change today▼ 3.27%▼ 2.68%
Market cap$1.72B$1.81B
Return, 3 months+6.0%-9.1%
Return, year to date-24.3%-0.7%
Return, 1 year-13.5%+8.8%
P/E (TTM)–49.3
P/B4.07.0
P/E percentile vs own 5y44th100th
Dividend yield––
Revenue growth (YoY, latest qtr)–+828.7%
Net profit growth (YoY)-59.4%+986.1%
Gross margin––
Operating margin-820.8%16.6%
Net margin-757.4%16.3%
Return on equity-37.5%15.0%
Analyst target vs. price+96.9%+60.0%
Analyst buy share100%100%
RSI (14)4743
30-day volatility58.6%56.5%
Max drawdown, 1 year-56.8%-23.6%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ZYME is the largest of the group by market value.
  • ZYME has returned the most over the past year.
  • ZYME keeps the most profit per dollar of sales.
  • ZYME has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top